Curevo Vaccine

CEO - George Simeon
CEO - George Simeon
USA | Funding: $196M (+)

Website: https://curevovaccine.com/

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.